Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: a case report

INTRODUCTION: sorafenib, a tyrosine-kinase inhibitor, is widely used in the treatment of advanced hepatocellular carcinoma. Drug-related toxicities are generally mild but sorafenib, as other similar agents, may induce elevation of systemic arterial blood pressure levels in relation to an interaction...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Valsuani, Chiara, Siclari, Olimpia, Camerini, Andrea, Canale, Maria Laura, Rondini, Marianna, Donati, Sara, Puccinelli, Paolo, Tartarelli, Gianna, Puccetti, Cheti, Amoroso, Domenico
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2009
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2803930/
https://ncbi.nlm.nih.gov/pubmed/20062650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1757-1626-2-9133
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller